(Q43740705)

26 November 2017

title

A semi-mechanistic model of the relationship between average glucose and HbA1c in healthy and diabetic subjects (English)

1 reference

26 November 2017

3

Mats O Karlsson

1 reference

26 November 2017

Rocío Lledó-García

1

1 reference

26 November 2017

Norman A Mazer

series ordinal

2

1 reference

26 November 2017

publication date

10 January 2013

1 reference

26 November 2017

number of pages

14

1 reference

Journal of Pharmacokinetics and Pharmacodynamics

inferred from page(s)

published in

1 reference

26 November 2017

volume

40

1 reference

26 November 2017

issue

2

1 reference

26 November 2017

page(s)

129-142

1 reference

https://scigraph.springernature.com/pub.10.1007/s10928-012-9289-6

26 November 2017

exact match

0 references

cites work

Translating the A1C assay into estimated average glucose values

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

The clinical information value of the glycosylated hemoglobin assay

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Diabetes control and complications: the role of glycated haemoglobin, 25 years on.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

A review of the challenge in measuring hemoglobin A1c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Approved IFCC reference method for the measurement of HbA1c in human blood

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Red cell life span heterogeneity in hematologically normal people is sufficient to alter HbA1c

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

High and low hemoglobin glycation phenotypes in type 1 diabetes: a challenge for interpretation of glycemic control

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Assessment of the relationship between glucose and A1c using kinetic modeling.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Use of prior information to stabilize a population data analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

ATP-dependent sugar transport complexity in human erythrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Models for plasma glucose, HbA1c, and hemoglobin interrelationships in patients with type 2 diabetes following tesaglitazar treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

A mechanism-based disease progression model for comparison of long-term effects of pioglitazone, metformin and gliclazide on disease processes underlying Type 2 Diabetes Mellitus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Modeling of red blood cell life-spans in hematologically normal populations

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Relationship between GHb concentration and erythrocyte survival determined from breath carbon monoxide concentration

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

A model for glucose, insulin, and beta-cell dynamics in subjects with insulin resistance and patients with type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Stability over time of glycohemoglobin, glucose, and red blood cell survival in hematologically stable people without diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Validation of hemoglobin glycation models using glycemia monitoring in vivo and culturing of erythrocytes in vitro.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Relationship of A1C to glucose concentrations in children with type 1 diabetes: assessments by high-frequency glucose determinations by sensors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Reversible hematologic sequelae of diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Lowered membrane fluidity of younger erythrocytes in diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

The biosynthesis of human hemoglobin A1c. Slow glycosylation of hemoglobin in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Evidence for interindividual heterogeneity in the glucose gradient across the human red blood cell membrane and its relationship to hemoglobin glycation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

The IFCC Reference Measurement System for HbA1c: a 6-year progress report.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Population pharmacokinetics and pharmacodynamics of peptidic erythropoiesis receptor agonist (ERA) in healthy volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS10928-012-9289-6

Tests of glycemia in diabetes

21 January 2018

1 reference

12 December 2020

Hemoglobin loss from erythrocytes in vivo results from spleen-facilitated vesiculation

1 reference

12 December 2020

Relationship between glycated haemoglobin levels and mean glucose levels over time

1 reference

12 December 2020

Global standardization of glycated hemoglobin measurement: the position of the IFCC Working Group.

1 reference

12 December 2020

Diabetic RBC-induced oxidant stress leads to transendothelial migration of monocyte-like HL-60 cells

1 reference

12 December 2020

Kinetic analysis of the nonenzymatic glycosylation of hemoglobin

1 reference

12 December 2020

Global harmonization of hemoglobin A1c

1 reference

12 December 2020

Xpose--an S-PLUS based population pharmacokinetic/pharmacodynamic model building aid for NONMEM

1 reference

12 December 2020

Feasibility of Improved Blood Glucose Control in Patients With Insulin-Dependent Diabetes Mellitus

1 reference

12 December 2020

Comparison of percent total GHb with percent HbA1c in people with and without known diabetes

1 reference

12 December 2020

Implementation of haemoglobin A1c results traceable to the IFCC reference system: the way forward

1 reference

12 December 2020

Glucosylation of human haemoglobin A. Dynamic variation in HbA1c described by a biokinetic model

1 reference

12 December 2020

A pharmacodynamic model of erythropoietin therapy for uremic anemia

1 reference

12 December 2020

A simple carbon monoxide breath test to estimate erythrocyte turnover

1 reference

12 December 2020

A theoretical model to predict the behavior of glycosylated hemoglobin levels

1 reference

12 December 2020

Glucosylation of human haemoglobin a in red blood cells studied in vitro. Kinetics of the formation and dissociation of haemoglobin A1c

1 reference

12 December 2020

Glycosylated haemoglobin and steady-state mean blood glucose concentration in Type 1 (insulin-dependent) diabetes

1 reference

12 December 2020

10.1007/S10928-012-9289-6

Identifiers

DOI

1 reference

26 November 2017

1 reference